Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Curr Microbiol ; 38(2): 126-31, 1999 Feb.
Article in English | MEDLINE | ID: mdl-9871112

ABSTRACT

Group B streptococci (GBS) colonizing the vagina and rectum of pregnant women cause invasive disease of the offspring in a small number of cases. The immune status of the host and differences in virulence among strains appear to be the main determinants for neonatal infection. A high-virulence clone (HVC) was proposed to cause much of the morbidity and mortality when a collection of GBS isolates was examined by multilocus enzyme electrophoresis. HVC isolates could be further distinguished by their inability to grow at 40 degrees C. This characteristic was used in the present study to examine a collection of 57 GBS isolates from Mexico City for the HVC. Three serotype III invasive strains were classified in the HVC. The other eleven invasive strains and all carrier isolates had growth curves unaffected at 40 degrees C. These results demonstrate the presence of the HVC in Mexico. Such a low prevalence could explain in part the low rate of GBS invasive neonatal disease in Mexico.


Subject(s)
Streptococcus agalactiae/isolation & purification , Adult , Female , Humans , Infant , Infant, Newborn , Mexico , Streptococcus agalactiae/growth & development , Streptococcus agalactiae/pathogenicity , Temperature , Virulence
2.
J Clin Microbiol ; 35(11): 2923-6, 1997 Nov.
Article in English | MEDLINE | ID: mdl-9350760

ABSTRACT

The low incidence of group B streptococcal (GBS) invasive neonatal disease in Mexico has been attributed to the low prevalence of serotype III strains, a major serotype in developed countries. In addition, nontypeable strains account for 12% of the isolates in Mexico and < 1% of the isolates in the United States. In this study, 57 GBS isolates (28 nontypeable by the Lancefield procedure) from carrier and infected neonates and women from Mexico were also examined for the presence of type-specific antigen by an enzymatic procedure using N-acetylmuramidase digestion of the cell wall to release soluble type-specific antigen. Of the 28 nontypeable strains from Mexico, 23 were typeable by the enzyme extraction procedure, with serotype III being the predominant serotype in invasive disease. These results suggest that nontypeable isolates of GBS should be further examined by the enzymatic extraction procedure to determine the presence of type-specific antigen. Furthermore, these limited results suggest that serotype III is likely a major serotype in invasive disease also in Mexico.


Subject(s)
Antigens, Bacterial/analysis , Streptococcal Infections/epidemiology , Streptococcus agalactiae/physiology , Antigens, Bacterial/biosynthesis , Carrier State/epidemiology , Female , Humans , Infant, Newborn , Mexico/epidemiology , Serotyping/methods , Streptococcal Infections/transmission , Streptococcus agalactiae/classification , Streptococcus agalactiae/pathogenicity , United States/epidemiology
3.
J Infect Dis ; 167(5): 1118-22, 1993 May.
Article in English | MEDLINE | ID: mdl-8486944

ABSTRACT

Pregnant Swiss-Webster mice were vaginally inoculated with 10(5) virulent and avirulent serotype III Streptococcus agalactiae and treated 4 days later with topical vaginal inhibitor solutions. Preparations containing lipoteichoic acid (LTA) or glycerophosphate (GP), the repeating linear backbone of LTA, significantly reduced neonatal colonization and bacteremia by the virulent isolate and colonization by the avirulent strain. Similar results were obtained if bacteria were preincubated with LTA or GP at 37 degrees C for 30 min before vaginal inoculation. Human serum albumin (HSA), a known inhibitor of binding of LTA to human fetal epithelial cells, also resulted in reduction in colonization and bacteremia of neonatal mice. However, maternal treatment with a combination of HSA (2%) and GP (1%) completely prevented neonatal colonization and bacteremia without altering the normal aerobic bacterial vaginal flora. These results provide impetus to the development of an alternative means of preventing neonatal group B streptococcal infections in humans without requiring maternal immunization or chemoprophylaxis.


Subject(s)
Glycerophosphates/therapeutic use , Streptococcal Infections/prevention & control , Streptococcus agalactiae/growth & development , Animals , Animals, Newborn , Female , Glycerophosphates/administration & dosage , Lipopolysaccharides/administration & dosage , Lipopolysaccharides/therapeutic use , Mice , Pregnancy , Serum Albumin/therapeutic use , Teichoic Acids/administration & dosage , Teichoic Acids/therapeutic use , Vaginal Creams, Foams, and Jellies
4.
J Clin Microbiol ; 28(7): 1676-7, 1990 Jul.
Article in English | MEDLINE | ID: mdl-2199528

ABSTRACT

A high-virulence clone of serotype III Streptococcus agalactiae causing invasive neonatal disease was previously identified by multilocus enzyme electrophoresis. A simple procedure involving growth at 40 degrees C distinguished all isolates classified in this high-virulence clone from other serotype III isolates, which are more frequently associated with asymptomatically colonized infants, as well as the other serotypes of group B streptococci. The high-virulence clone failed to grow at 40 degrees C in FMC, a chemically defined medium, in contrast to the other organisms, which grew readily.


Subject(s)
Streptococcus agalactiae/growth & development , Bacteriological Techniques , Humans , Infant, Newborn , Serotyping , Streptococcus agalactiae/classification , Streptococcus agalactiae/pathogenicity , Temperature , Virulence
SELECTION OF CITATIONS
SEARCH DETAIL
...